A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022.

A sponge-like implant in mice has helped guide a treatment that slowed or stopped a degenerative condition similar to ...

A new UCLA Health study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are most vulnerable in Huntington's disease ...

Researchers discovered a previously unknown mechanism that may drive tissue damage and a new target for drug discovery.

Medications are the mainstay of treatment for multiple sclerosis (MS). Many of them are used to block the immune system's attack on the nerves and slow or prevent progression and relapses (flare-ups) ...

Multiple sclerosis (MS) is a chronic (long-term) condition with symptoms that vary from person to person. With proper management of symptoms, people living with MS can often remain active for many ...

The pathophysiology of multiple sclerosis (MS) is characterized by demyelination, which culminates in a reduction in axonal transmission. Axonal and neuronal degeneration seem to be concomitant ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Mothers with multiple sclerosis (MS) had a higher risk of peripartum mental illness compared with mothers without MS ...

Injectable medications for multiple sclerosis (MS) are known as disease-modifying therapies (DMTs). This means they work by slowing or changing the progression of the condition. These are self ...

Department of Neurology, Neurological Diagnosis and Treatment Center, Jinan Third People’s Hospital, Jinan, China Background: Ofatumumab, a fully human monoclonal antibody targeting CD20, is approved ...

Background Limited data are available on the global rates of paediatric multiple sclerosis. Here, we report on the estimated worldwide prevalence of paediatric MS. Methods We included paediatric ...